Non-ownership Filings
| Positive Eroxon® & Eroxon® “Intense” HUT results | Mar. 23, 2026 |
| Formal Grant of US Patent | Mar. 18, 2026 |
| Holding(s) in Company | Mar. 17, 2026 |
| Holding(s) in Company | Feb. 20, 2026 |
| Trading Update | Feb. 04, 2026 |
| Holding(s) in Company | Jan. 13, 2026 |
| Holding(s) in Company | Jan. 13, 2026 |
Ownership Update Filings
| Directors' / PDMR dealing | Dec. 08, 2025 |
| PCA Dealing | Nov. 14, 2025 |
| Remuneration of Non-Executive Directors and TVR's | Jan. 13, 2025 |
| Holding(s) in Company | Dec. 20, 2024 |
| TR-1: Notification of major holdings | Nov. 15, 2024 |
| Directors’ / PDMR Dealing | Sep. 13, 2024 |
| Directors’ / PDMR Dealing and Grant of Options | Apr. 29, 2024 |